A hospital-based cohort study finds that elevated alkaline phosphatase and hyperphosphatemia predict mortality in chronic kidney disease, indicating a need for better risk assessment.
Elevated ALP independently predicted mortality, while hyperphosphatemia predicted both mortality and CKD progression. Monitoring these biomarkers may improve risk stratification and guide future interventional studies.
No takes yet. Share an insight, caveat, or question.
Rashid et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: